5
Japan Endovascular Treatment Conference 2014 apan Endovascular Treatment Conference 2014 JET2014 コココココココココココ

COI Disclosure; Name , MD

Embed Size (px)

DESCRIPTION

COI Disclosure; Name , MD. For the 12 months preceding this CME activity, I disclose the following types of financial relationships: Honoraria received from: Consulted for: Held common stock in: Research , clinical trial, or drug study funds received from : - PowerPoint PPT Presentation

Citation preview

Page 1: COI Disclosure;  Name ,  MD

Japan Endovascular Treatment Conference 2014Japan Endovascular Treatment Conference 2014

JET2014  コメディカルセッション

Page 2: COI Disclosure;  Name ,  MD

Japan Endovascular Treatment Conference 2014Japan Endovascular Treatment Conference 20

COI Disclosure; Name, MD.

For the 12 months preceding this CME activity, I disclose the following types of financial relationships:•Honoraria received from:•Consulted for:•Held common stock in:•Research, clinical trial, or drug study funds received from:• I WILL or WILL NOT be discussing products that are

investigational or not labeled for use under discussion.

Page 3: COI Disclosure;  Name ,  MD

Japan Endovascular Treatment Conference 2014Japan Endovascular Treatment Conference 20

Page 4: COI Disclosure;  Name ,  MD

Japan Endovascular Treatment Conference 2014

Page 5: COI Disclosure;  Name ,  MD

Japan Endovascular Treatment Conference 2014

Thank you for your attention

JET2014 Hilton Tokyo Hotel

February 14(Fri)-16(Sun)2014